Generics

Originals

Biosimilars

Medical devices

Nutraceuticals 2

Filters

Berberis aristata manufacturers

2 products found

Filters

2 products found

berberis aristata + sylimarin

Tablets, buccal 500 mg + 100 mg

Country of origin
European Union
GMP approvals
IT
Recommended use
Heart and circulation, Digestive health
Product description
INDICATED in DYSLIPIDEMIC PATIENTS STATIN INTOLERANT as monotherapy or in add on to Ezetimibe INDICATED in DIABETIC PATIENTS as monotherapy or in add on to Metformine INDICATED in PATIENTS with METABOLIC SYNDROME
Unavailable markets
Italy
Registered in
Italy
Available for
White label, Manufacturer's brand
Manufacturer #10824
This biopharmaceutical company specializes in developing innovative nutraceutical and herbal-derivative products, leveraging a strong research and development foundation with over 40 patents and 200 scientific publications. They focus on three primary product lines: biopharmaceuticals that enhance the efficacy of nutraceuticals and herbal extracts; Metabolic Care formulations addressing metabolic health; and Bacterial Care products featuring probiotics and prebiotics. Key therapy areas include gastroenterology, gynecology, immunology, oncology, pediatrics, and urology. They hold GMP certifications and their products are available in major regions like North America and the EU.

Want to see all 2 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible